Analysts Set The Cooper Companies, Inc. (NASDAQ:COO) PT at $109.48

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average rating of “Moderate Buy” from the ten ratings firms that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $109.48.

A number of equities research analysts have commented on the stock. Mizuho raised their target price on shares of Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Citigroup raised their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. TheStreet cut shares of Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. Piper Sandler raised their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Friday, March 1st. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $110.00 price objective (up previously from $105.00) on shares of Cooper Companies in a research report on Friday, March 1st.

Cooper Companies Stock Performance

COO opened at $92.40 on Friday. The company has a current ratio of 1.86, a quick ratio of 1.08 and a debt-to-equity ratio of 0.35. The company has a market cap of $18.37 billion, a price-to-earnings ratio of 62.56, a PEG ratio of 2.30 and a beta of 0.97. The company’s 50 day moving average is $96.79 and its 200 day moving average is $91.89. Cooper Companies has a 12-month low of $75.93 and a 12-month high of $104.07.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, February 29th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Cooper Companies had a net margin of 7.93% and a return on equity of 8.79%. The company had revenue of $931.60 million for the quarter, compared to the consensus estimate of $915.93 million. During the same quarter last year, the firm posted $2.90 earnings per share. The firm’s revenue was up 8.5% compared to the same quarter last year. On average, equities research analysts predict that Cooper Companies will post 3.5 EPS for the current year.

Insider Buying and Selling

In related news, CAO Agostino Ricupati sold 54,724 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the sale, the chief accounting officer now owns 5,081 shares in the company, valued at $512,622.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Gary S. Petersmeyer sold 1,000 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $103.51, for a total value of $103,510.00. Following the sale, the director now owns 5,668 shares in the company, valued at $586,694.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Agostino Ricupati sold 54,724 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $100.89, for a total transaction of $5,521,104.36. Following the completion of the sale, the chief accounting officer now directly owns 5,081 shares in the company, valued at approximately $512,622.09. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cooper Companies

Hedge funds have recently added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC bought a new position in shares of Cooper Companies during the third quarter valued at approximately $26,000. Blue Trust Inc. increased its stake in Cooper Companies by 54.8% in the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34 shares during the period. Lindbrook Capital LLC lifted its position in shares of Cooper Companies by 182.5% during the fourth quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock worth $43,000 after purchasing an additional 73 shares during the last quarter. Venturi Wealth Management LLC lifted its position in shares of Cooper Companies by 60.5% during the third quarter. Venturi Wealth Management LLC now owns 138 shares of the medical device company’s stock worth $44,000 after purchasing an additional 52 shares during the last quarter. Finally, Desjardins Global Asset Management Inc. grew its holdings in shares of Cooper Companies by 44.8% in the fourth quarter. Desjardins Global Asset Management Inc. now owns 152 shares of the medical device company’s stock worth $58,000 after purchasing an additional 47 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.